{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&uin=HL2220&creator.label=Biography+information+for+Lord+Moonie", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?registeredInterest=false&uin=HL2220&creator.label=Biography+information+for+Lord+Moonie", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&uin=HL2220&_metadata=all&creator.label=Biography+information+for+Lord+Moonie", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&registeredInterest=false&uin=HL2220&creator.label=Biography+information+for+Lord+Moonie", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&uin=HL2220&creator.label=Biography+information+for+Lord+Moonie", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?registeredInterest=false&uin=HL2220&creator.label=Biography+information+for+Lord+Moonie", "items" : [{"_about" : "http://data.parliament.uk/resources/773019", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/773019/answer", "answerText" : {"_value" : "<p>The United Kingdom Government considers international inter-governmental co-operation to be essential in the development of new antibiotics.<\/p><p>Through international forums, in particular the G20, the UK Government is advocating tangible actions that will incentivise pharmaceutical companies to produce effective, accessible and affordable new antibiotics. The Government is also investing internationally in early-stage research and development to address antimicrobial resistance, in partnership with other countries and organisations, through projects such as the Global Anti-Microbial Resistance Innovation Fund.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
        , "dateOfAnswer" : {"_value" : "2017-11-01", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-11-01T16:05:22.657Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2017-10-18", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Antibiotics: Research"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what is their policy on international intergovernmental co-operation to offset market failures in the development of new antibiotics.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/621", "label" : {"_value" : "Biography information for Lord Moonie"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Moonie"}
      ], "uin" : "HL2220"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}